GlassScriptPhysician profile
Tamara Myree Harris
NPI 1477193217
$1,915.37
in general payments reported to CMS, 2019-2025
17 companies · $507 in 2025
The $507 reported for 2025 was more than what 78% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
See the full distribution for Acute Care (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $525 · 2022: $219 · 2023: $316 · 2024: $348 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $631.60 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $432.70 | 2021-2025 | Wainua, Farxiga |
| Alnylam Pharmaceuticals INC. | $256.80 | 2023-2024 | Amvuttra, Onpattro |
| Pfizer INC. | $115.13 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $78.12 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $61.94 | 2022-2025 | Camzyos |
| Veloxis Pharmaceuticals, INC. | $57.62 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.04 | 2021-2022 | |
| Abiomed | $45.75 | 2024 | Impella |
| Novartis Pharmaceuticals Corporation | $38.33 | 2021-2023 | |
| Kestra Medical Technology Services, INC. | $30.90 | 2022 | |
| Bridgebio Pharma, INC. | $26.59 | 2025 | Attruby |
| Cvrx, INC. | $20.01 | 2025 | Barostim Neo System |
| Boston Scientific Corporation | $19.07 | 2025 | Resonate El Icd Vr |
| Impulse Dynamics (USA) INC. | $17.12 | 2023 | Optimizer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $15.56 | 2024 | Paradise Renal Denervation System |
| Scpharmaceuticals INC. | $14.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.